BXRX
Income statement / Annual
Last year (2022), Baudax Bio, Inc.'s total revenue was $1.27 M,
an increase of 17.50% from the previous year.
In 2022, Baudax Bio, Inc.'s net income was -$58.80 M.
See Baudax Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$1.27 M
|
$1.08 M
|
$493,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$7.01 M |
$2.45 M |
$1.73 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$5.74 M |
-$1.37 M |
-$1.24 M |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
-4.52 |
-1.26 |
-2.51 |
0 |
0 |
0 |
| Research and Development
Expenses |
$5.88 M
|
$3.13 M
|
$9.09 M
|
$20.06 M
|
$35.58 M
|
$28.64 M
|
| General & Administrative
Expenses |
$14.71 M
|
$0.00
|
$0.00
|
$27.01 M
|
$29.45 M
|
$19.63 M
|
| Selling & Marketing
Expenses |
$9.41 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$24.12 M
|
$45.31 M
|
$43.34 M
|
$27.01 M
|
$29.45 M
|
$19.63 M
|
| Other Expenses |
$0.00 |
$2.58 M |
$2.15 M |
-$38,000.00 |
-$132,000.00 |
$16,000.00 |
| Operating Expenses |
$30.00 M |
$51.01 M |
$54.57 M |
$47.07 M |
$65.04 M |
$48.26 M |
| Cost And Expenses |
$37.01 M |
$53.46 M |
$56.30 M |
$47.07 M |
$65.04 M |
$48.26 M |
| Interest Income |
$0.00 |
$0.00 |
$1.36 M |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$21.07 M |
$2.30 M |
$1.36 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$2.16 M
|
-$29.25 M
|
$21.58 M
|
-$28.63 M
|
$396,000.00
|
$72,000.00
|
| EBITDA |
-$35.58 M
|
-$48.26 M
|
-$74.79 M
|
-$39.39 M
|
-$56.14 M
|
-$35.35 M
|
| EBITDA Ratio |
-28.04 |
-44.69 |
-107.93 |
0 |
0 |
0 |
| Operating Income Ratio
|
-28.17
|
-17.6
|
-151.7
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$23.05 M
|
$32.61 M
|
-$1.31 M
|
$7.32 M
|
-$8.63 M
|
-$12.82 M
|
| Income Before Tax |
-$58.80 M |
-$19.77 M |
-$76.10 M |
-$32.56 M |
-$73.67 M |
-$61.08 M |
| Income Before Tax Ratio
|
-46.33
|
-18.3
|
-154.36
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$3.84 M |
$1.40 M |
-$14.55 M |
-$132,000.00 |
$12.84 M |
| Net Income |
-$58.80 M |
-$19.77 M |
-$76.10 M |
-$18.00 M |
-$73.67 M |
-$61.08 M |
| Net Income Ratio |
-46.33 |
-18.3 |
-154.36 |
0 |
0 |
0 |
| EPS |
-177.3 |
-361.16 |
-5715.36 |
-2695.87 |
-11361.35 |
-9420.73 |
| EPS Diluted |
-177.3 |
-361.16 |
-5715.36 |
-2695.87 |
-11361.35 |
-9420.73 |
| Weighted Average Shares
Out |
$331,615.00
|
$54,738.00
|
$13,315.00
|
$6,678.00
|
$6,484.00
|
$6,484.00
|
| Weighted Average Shares
Out Diluted |
$331,615.00
|
$54,738.00
|
$13,315.00
|
$6,678.00
|
$6,484.00
|
$6,484.00
|
| Link |
|
|
|
|
|
|
